NCIC CTG IND.181: Phase I study of AT9283 given as a weekly 24 hour infusion in advanced malignanciesDENT, S. F; GELMON, K. A; CHI, K. N et al.Investigational new drugs. 2013, Vol 31, Num 6, pp 1522-1529, issn 0167-6997, 8 p.Article

A phase II trial of dacomitinib, an oral pan-human EGF receptor (HER) inhibitor, as first-line treatment in recurrent and/or metastatic squamous-cell carcinoma of the head and neckABDUL RAZAK, A. R; SOULIERES, D; CHAN, K. K et al.Annals of oncology. 2013, Vol 24, Num 3, pp 761-769, issn 0923-7534, 9 p.Article

Randomised, double-blind trial of carboplatin and paclitaxel with daily oral cediranib or placebo in patients with advanced non-small cell lung cancer: NCIC Clinical Trials Group study BR29LAURIE, S. A; SOLOMON, B. J; FENTON, D et al.European journal of cancer (1990). 2014, Vol 50, Num 4, pp 706-712, issn 0959-8049, 7 p.Article

A phase II study of sunitinib in recurrent and/or metastatic adenoid cystic carcinoma (ACC) of the salivary glands: current progress and challenges in evaluating molecularly targeted agents in ACCCHAU, N. G; HOTTE, S. J; CHEN, E. X et al.Annals of oncology. 2012, Vol 23, Num 6, pp 1562-1570, issn 0923-7534, 9 p.Article

A Phase I study of cyclin-dependent kinase inhibitor, AT7519, in patients with advanced cancer: NCIC Clinical Trials Group IND 177CHEN, E. X; HOTTE, S; HIRTE, H et al.British journal of cancer. 2014, Vol 111, Num 12, pp 2262-2267, issn 0007-0920, 6 p.Article

In vivo RAF signal transduction as a potential biomarker for sorafenib efficacy in patients with neuroendocrine tumoursQUINTELA-FANDINO, M; KRZYZANOWSKA, M; WEBSTER, S et al.British journal of cancer. 2013, Vol 108, Num 6, pp 1298-1305, issn 0007-0920, 8 p.Article

Correlation of changes between 2-year disease-free survival and 5-year overall survival in adjuvant breast cancer trials from 1966 to 2006NG, R; POND, G. R; TANG, P. A et al.Annals of oncology. 2008, Vol 19, Num 3, pp 481-486, issn 0923-7534, 6 p.Article

Phase 1 study of nab-paclitaxel, cisplatin and 5-fluorouracil as induction chemotherapy followed by concurrent chemoradiotherapy in locoregionally advanced squamous cell carcinoma of the oropharynxLOONG, H. H; WINQUIST, E; BAYLEY, A et al.European journal of cancer (1990). 2014, Vol 50, Num 13, pp 2263-2270, issn 0959-8049, 8 p.Article

A phase I study of the combination of ro4929097 and cediranib in patients with advanced solid tumours (PJC-004/NCI 8503)SAHEBJAM, S; BEDARD, P. L; KAMEL-REID, S et al.British journal of cancer. 2013, Vol 109, Num 4, pp 943-949, issn 0007-0920, 7 p.Article

Estimating zero-plane displacement height and aerodynamic roughness length using synthesis of LiDAR and SPOT-5 dataTIAN, X; LI, Z. Y; VAN DER TOL, C et al.Remote sensing of environment. 2011, Vol 115, Num 9, pp 2330-2341, issn 0034-4257, 12 p.Article

Phase I clinical, pharmacokinetic and pharmacodynamic study of SB939, an oral histone deacetylase (HDAC) inhibitor, in patients with advanced solid tumoursRAZAK, Ara; HOTTE, S. J; ZHU, J et al.British journal of cancer. 2011, Vol 104, Num 5, pp 756-762, issn 0007-0920, 7 p.Article

Influence of an independent review committee on assessment of response rate and progression-free survival in phase III clinical trialsTANG, P. A; POND, G. R; CHEN, E. X et al.Annals of oncology. 2010, Vol 21, Num 1, pp 19-26, issn 0923-7534, 8 p.Article

A phase I, first in man study of OSI-7836 in patients with advanced refractory solid tumors : IND.147, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials GroupGOSS, G; SIU, L. L; DROLET, D. W et al.Cancer chemotherapy and pharmacology. 2006, Vol 58, Num 5, pp 703-710, issn 0344-5704, 8 p.Article

Phase I trial of UCN-01 in combination with topotecan in patients with advanced solid cancers : a Princess Margaret Hospital Phase II Consortium studyHOTTE, S. J; OZA, A; WINQUIST, E. W et al.Annals of oncology. 2006, Vol 17, Num 2, pp 334-340, issn 0923-7534, 7 p.Article

Development of a marine fish model for studying in vivo molecular responses in ecotoxicologyKONG, R. Y. C; GIESY, J. P; WU, R. S. S et al.Aquatic toxicology. 2008, Vol 86, Num 2, pp 131-141, issn 0166-445X, 11 p.Article